Porton Pharma Solutions Balance Sheet Health
Financial Health criteria checks 3/6
Porton Pharma Solutions has a total shareholder equity of CN¥5.6B and total debt of CN¥1.4B, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are CN¥8.9B and CN¥3.4B respectively.
Key information
24.7%
Debt to equity ratio
CN¥1.37b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.40b |
| Equity | CN¥5.55b |
| Total liabilities | CN¥3.37b |
| Total assets | CN¥8.92b |
Recent financial health updates
Porton Pharma Solutions (SZSE:300363) Has Debt But No Earnings; Should You Worry?
Sep 25
Is Porton Pharma Solutions (SZSE:300363) Weighed On By Its Debt Load?
Jun 26Does Porton Pharma Solutions (SZSE:300363) Have A Healthy Balance Sheet?
Mar 26Recent updates
Revenues Not Telling The Story For Porton Pharma Solutions Ltd. (SZSE:300363) After Shares Rise 31%
Nov 14Porton Pharma Solutions Ltd.'s (SZSE:300363) 39% Price Boost Is Out Of Tune With Revenues
Sep 30Porton Pharma Solutions (SZSE:300363) Has Debt But No Earnings; Should You Worry?
Sep 25Is Porton Pharma Solutions (SZSE:300363) Weighed On By Its Debt Load?
Jun 26Analysts Just Shaved Their Porton Pharma Solutions Ltd. (SZSE:300363) Forecasts Dramatically
May 02Does Porton Pharma Solutions (SZSE:300363) Have A Healthy Balance Sheet?
Mar 26Porton Pharma Solutions Ltd.'s (SZSE:300363) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
Mar 04Financial Position Analysis
Short Term Liabilities: 300363's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥1.5B).
Long Term Liabilities: 300363's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥1.9B).
Debt to Equity History and Analysis
Debt Level: 300363 has more cash than its total debt.
Reducing Debt: 300363's debt to equity ratio has increased from 18.5% to 24.7% over the past 5 years.
Debt Coverage: 300363's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 300363's interest payments on its debt are well covered by EBIT.